[시장보고서]혈관성형술용 풍선 시장 : 유형별, 용도별, 최종사용자별

혈관성형술용 풍선 시장 : 유형별, 용도별, 최종사용자별 - 세계 기회 분석 및 산업 예측(2024-2033년)

Angioplasty Balloons Market By Type , By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

상품코드 : 1566823

리서치사 : Allied Market Research

발행일 : 2024년 07월

페이지 정보 : 영문 260 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,425

￦ 6,091,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 7,412

￦ 10,204,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

혈관성형술용 풍선 시장은 2023년 26억 달러로 평가되며, 2024-2033년 연평균 3.4% 성장하여 2033년에는 36억 달러에 달할 것으로 예상됩니다.

혈관성형술용 풍선은 혈관 내 장치로, 막히거나 좁아진 혈관을 여는 데 사용되는 최소침습적 혈관 내 장치입니다. 이 장치는 적절한 혈류를 회복시켜 관상동맥 질환, 심장마비 및 기타 심장 질환의 증상을 완화합니다. 이 시술은 일반적으로 개심술보다 저렴하여 많은 환자들에게 비용 효율적인 선택이 될 수 있습니다.

세계 혈관성형술용 풍선 시장의 성장을 주도하고 있는 것은 심혈관질환의 심각한 유병률 증가입니다. 세계심장연맹에 따르면 심혈관계 질환은 다른 어떤 원인보다 전 세계 사망 원인 1위입니다. 매년 약 2,050만 명이 심혈관질환으로 사망합니다. 이 중 85%는 관상동맥성 심장질환(심장마비 등)과 뇌혈관질환(뇌졸중 등)으로 인한 것입니다. 또한, 노인 인구의 증가가 시장 성장에 크게 기여하고 있습니다. 이는 노인들이 심장 질환에 매우 취약하다는 사실에 기인합니다. 스페인 심장학회의 공식 간행물인 Revista Espanola de Cardiologia가 발표한 논문에 따르면, 관상동맥성 심장질환은 65세 이상 성인의 81%가 사망하는 원인이라고 합니다. 또한, 혈관성형술과 같은 최소침습적 수술은 회복이 빠르고 입원 기간이 짧아 환자와 의료 서비스 제공자 사이에서 선호도가 높아져 시장 성장을 촉진하고 있습니다. 그러나 혈관성형술의 높은 비용과 동맥 박리 및 재협착과 같은 혈관성형술에 따른 합병증은 시장 성장을 저해하는 요인으로 작용하고 있습니다. 반면, 풍선 디자인, 재료, 영상 기술의 지속적인 개선으로 혈관성형술의 효과와 안전성이 향상됨에 따라 예측 기간 동안 시장 확대의 기회가 될 것으로 예상됩니다.

세계 혈관성형술용 풍선 시장은 유형, 용도, 최종사용자, 지역으로 구분됩니다. 유형별로는 일반 풍선, 약물 용출 풍선, 커팅 풍선, 스코어링 풍선으로 나뉩니다. 용도별로는 말초와 관상동맥으로 나뉩니다. 최종사용자에 따라 ASC, 병원, 카테터 실험실로 분류됩니다. 지역별로는 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카로 분석됩니다.

주요 조사 결과

유형별로는 일반 풍선 부문이 2023년 주요 수익원이었습니다.

용도별로는 관상동맥 부문이 2023년 혈관성형술 풍선 시장에서 가장 큰 점유율을 차지했습니다.

최종사용자별로는 ASCs 부문이 2023년 주요 주주로 나타났습니다.

지역별로는 북미가 2023년 가장 높은 매출을 기록했으며, 예측 기간 동안 시장을 장악할 것으로 보입니다.

이 보고서는 사용자 정의가 가능합니다.

고객의 관심사에 따른 기업 프로파일 추가

시장 개요
북미
- 주요 시장 동향과 기회
- 미국의 혈관성형술용 풍선 시장
- 캐나다의 혈관성형술용 풍선 시장
- 멕시코의 혈관성형술용 풍선 시장
유럽
- 주요 시장 동향과 기회
- 프랑스의 혈관성형술용 풍선 시장
- 독일의 혈관성형술용 풍선 시장
- 이탈리아의 혈관성형술용 풍선 시장
- 스페인의 혈관성형술용 풍선 시장
- 영국의 혈관성형술용 풍선 시장
- 기타 유럽의 혈관성형술용 풍선 시장
아시아태평양
- 주요 시장 동향과 기회
- 중국의 혈관성형술용 풍선 시장
- 일본의 혈관성형술용 풍선 시장
- 인도의 혈관성형술용 풍선 시장
- 한국의 혈관성형술용 풍선 시장
- 호주의 혈관성형술용 풍선 시장
- 기타 아시아태평양의 혈관성형술용 풍선 시장
라틴아메리카, 중동 및 아프리카
- 주요 시장 동향과 기회
- 브라질의 혈관성형술용 풍선 시장
- 남아프리카공화국의 공화국 혈관성형술용 풍선 시장
- 사우디아라비아의 혈관성형술용 풍선 시장
- 기타 라틴아메리카, 중동 및 아프리카의 혈관성형술용 풍선 시장

제8장 경쟁 상황

소개
주요 성공 전략
주요 10개 기업 제품 매핑
경쟁 대시보드
경쟁 히트맵
주요 기업의 포지셔닝(2023년)

제9장 기업 개요

Abbott Laboratories
B. Braun Melsungen AG
Biotronik SE And Co. KG
Boston Scientific Corporation
C. R. Bard, Inc.
Cardinal Health, Inc
MEDTRONIC PLC.
MicroPort Scientific Corporation
Terumo Corporation
THE SPECTRANETICS CORPORATION

ksm

영문 목차

영문목차

The angioplasty balloons market was valued at $2.6 billion in 2023, and is projected to reach $3.6 billion by 2033, growing at a CAGR of 3.4% from 2024 to 2033.

Angioplasty balloon is a minimally invasive endovascular device is used to open up blocked or narrowed blood vessels. This device enables to restore proper blood flow, alleviating the symptoms of coronary artery disease, heart attacks, and other cardiac diseases. The procedure is generally less expensive than open heart surgery, making it a cost-effective option for many patients.

The growth of the global angioplasty balloons market is driven by alarming increase in prevalence of cardiovascular diseases. According to the World Heart Federation, cardiovascular diseases are the leading cause of death worldwide as compared to any other cause. Approximately 20.5 million die every year due to cardiovascular diseases. Of these deaths, 85% are due to coronary heart diseases (e.g., heart attacks) and cerebrovascular diseases (e.g., strokes). Moreover, increase in geriatric population significantly contributes toward the growth of the market. This is attributed to the fact that aged individuals are highly susceptible to cardiac diseases. As per the article published by the Revista Espanola de Cardiologia-the official publication of the Spanish Society of Cardiology-coronary heart disease is the leading cause of death in 81% of adults aged 65 years or older. Furthermore, increase in preference for minimally invasive procedures among patients and healthcare providers like angioplasty due to quicker recovery times and reduced hospital stays foster the growth of the market. However, high cost of angioplasty and complications associated with angioplasty, such as arterial dissection or restenosis hamper the market growth. On the contrary, continuous improvements in balloon design, materials, and imaging technologies will enhance the efficacy and safety of angioplasty procedures, which are expected to offer remunerative opportunities for the expansion of the market during the forecast period.

The global angioplasty balloons market is segmented into type, application, end user, and region. On the basis of type, the market is classified into normal balloons, drug eluting balloons, cutting balloons, and scoring balloons. By application, it is bifurcated into peripheral and coronary. Depending on end user, it is segregated into ASCs, hospitals, and Cath labs. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the normal balloon segment was the major revenue generator in 2023.

By application, the coronary segment accounted for the largest share in 2023 in angioplasty balloons market.

Depending on end user, the ASCs segment held the was the key shareholder in 2023.

Region wise, North America generated the highest revenue in 2023 and is expected to dominate the market during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global angioplasty balloons market include Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc, MEDTRONIC PLC., MicroPort Scientific Corporation, Terumo Corporation, and THE SPECTRANETICS CORPORATION. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the global market.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Additional company profiles with specific to client's interest

Key Market Segments

By Type

Normal Balloons
Drug Eluting Balloons
Cutting Balloons
Scoring Balloons

By Application

Peripheral
Coronary

By End User

ASCs
Hospitals
Cath Labs

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA

Key Market Players:

Abbott Laboratories
B. Braun Melsungen AG
Biotronik SE & Co. KG
Boston Scientific Corporation
C. R. Bard, Inc.
Cardinal Health, Inc
MEDTRONIC PLC.
MicroPort Scientific Corporation
Terumo Corporation
THE SPECTRANETICS CORPORATION

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope
3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities

CHAPTER 4: ANGIOPLASTY BALLOONS MARKET, BY TYPE

4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Type
4.2. Normal Balloons
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
4.3. Drug Eluting Balloons
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
4.4. Cutting Balloons
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
4.5. Scoring Balloons
- 4.5.1. Key Market Trends, Growth Factors and Opportunities
- 4.5.2. Market Size and Forecast, By Region
- 4.5.3. Market Share Analysis, By Country

CHAPTER 5: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION

5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Application
5.2. Peripheral
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
5.3. Coronary
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country

CHAPTER 6: ANGIOPLASTY BALLOONS MARKET, BY END USER

6.1. Market Overview
- 6.1.1 Market Size and Forecast, By End User
6.2. ASCs
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
6.3. Hospitals
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
6.4. Cath Labs
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country

CHAPTER 7: ANGIOPLASTY BALLOONS MARKET, BY REGION

7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Type
- 7.2.3. Market Size and Forecast, By Application
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Angioplasty Balloons Market
  - 7.2.6.1. Market Size and Forecast, By Type
  - 7.2.6.2. Market Size and Forecast, By Application
  - 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada Angioplasty Balloons Market
  - 7.2.7.1. Market Size and Forecast, By Type
  - 7.2.7.2. Market Size and Forecast, By Application
  - 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico Angioplasty Balloons Market
  - 7.2.8.1. Market Size and Forecast, By Type
  - 7.2.8.2. Market Size and Forecast, By Application
  - 7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Type
- 7.3.3. Market Size and Forecast, By Application
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. France Angioplasty Balloons Market
  - 7.3.6.1. Market Size and Forecast, By Type
  - 7.3.6.2. Market Size and Forecast, By Application
  - 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. Germany Angioplasty Balloons Market
  - 7.3.7.1. Market Size and Forecast, By Type
  - 7.3.7.2. Market Size and Forecast, By Application
  - 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. Italy Angioplasty Balloons Market
  - 7.3.8.1. Market Size and Forecast, By Type
  - 7.3.8.2. Market Size and Forecast, By Application
  - 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Spain Angioplasty Balloons Market
  - 7.3.9.1. Market Size and Forecast, By Type
  - 7.3.9.2. Market Size and Forecast, By Application
  - 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. UK Angioplasty Balloons Market
  - 7.3.10.1. Market Size and Forecast, By Type
  - 7.3.10.2. Market Size and Forecast, By Application
  - 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest of Europe Angioplasty Balloons Market
  - 7.3.11.1. Market Size and Forecast, By Type
  - 7.3.11.2. Market Size and Forecast, By Application
  - 7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Type
- 7.4.3. Market Size and Forecast, By Application
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. China Angioplasty Balloons Market
  - 7.4.6.1. Market Size and Forecast, By Type
  - 7.4.6.2. Market Size and Forecast, By Application
  - 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. Japan Angioplasty Balloons Market
  - 7.4.7.1. Market Size and Forecast, By Type
  - 7.4.7.2. Market Size and Forecast, By Application
  - 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. India Angioplasty Balloons Market
  - 7.4.8.1. Market Size and Forecast, By Type
  - 7.4.8.2. Market Size and Forecast, By Application
  - 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. South Korea Angioplasty Balloons Market
  - 7.4.9.1. Market Size and Forecast, By Type
  - 7.4.9.2. Market Size and Forecast, By Application
  - 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. Australia Angioplasty Balloons Market
  - 7.4.10.1. Market Size and Forecast, By Type
  - 7.4.10.2. Market Size and Forecast, By Application
  - 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia-Pacific Angioplasty Balloons Market
  - 7.4.11.1. Market Size and Forecast, By Type
  - 7.4.11.2. Market Size and Forecast, By Application
  - 7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Type
- 7.5.3. Market Size and Forecast, By Application
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Angioplasty Balloons Market
  - 7.5.6.1. Market Size and Forecast, By Type
  - 7.5.6.2. Market Size and Forecast, By Application
  - 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. South Africa Angioplasty Balloons Market
  - 7.5.7.1. Market Size and Forecast, By Type
  - 7.5.7.2. Market Size and Forecast, By Application
  - 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. Saudi Arabia Angioplasty Balloons Market
  - 7.5.8.1. Market Size and Forecast, By Type
  - 7.5.8.2. Market Size and Forecast, By Application
  - 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. Rest of LAMEA Angioplasty Balloons Market
  - 7.5.9.1. Market Size and Forecast, By Type
  - 7.5.9.2. Market Size and Forecast, By Application
  - 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

9.1. Abbott Laboratories
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
9.2. B. Braun Melsungen AG
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
9.3. Biotronik SE And Co. KG
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
9.4. Boston Scientific Corporation
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
9.5. C. R. Bard, Inc.
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
9.6. Cardinal Health, Inc
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
9.7. MEDTRONIC PLC.
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
9.8. MicroPort Scientific Corporation
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
9.9. Terumo Corporation
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
9.10. THE SPECTRANETICS CORPORATION
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments